title: [Extracranial stereotactic radiotherapy for early-stage non-small cell lung cancer and oligometastases].
abstract: Stereotactic body radiotherapy (SBRT) is a new radiation technique that combines improvements in radiotherapy planning, intensity modulation and image guidance. The use of SBRT enables radiotherapy to be delivered instead of in six weeks in only a few days and with ablative total dose. Prospective phase II studies in patients with inoperable early stage non-small cell lung cancer demonstrate that the use of SBRT results in local control rates of 85-95% with acceptable toxicity. SBRT is also increasingly used for treatment of metastases in the lung, liver, retroperitoneum and in bones. Because SBRT enables a locally curative dose to be delivered in a time efficient manner this technique also opens up new perspectives for the treatment of patients with oligometastases.
authors.affiliation: Klinik und Poliklinik für Radio-Onkologie, Universitätsspital Zürich.
authors.forename: Oliver
authors.initials: O
authors.lastname: Riesterer
mesh_terms: D000368:Aged; D002289:Carcinoma, Non-Small-Cell Lung / Q000401:mortality / Q000473:pathology* / Q000601:surgery*; D002986:Clinical Trials as Topic; D018450:Disease Progression; D005500:Follow-Up Studies; D006801:Humans; D008175:Lung Neoplasms / Q000401:mortality / Q000473:pathology* / Q000556:secondary* / Q000601:surgery*; D011183:Postoperative Complications / Q000209:etiology / Q000401:mortality; D016634:Radiosurgery / Q000379:methods*; D015996:Survival Rate; D013557:Switzerland
keywords: Bronchialkarzinom; Oligometastasen; cancer du poumon; extracranial stereotactic radiotherapy; extrakranielle stereotaktische Radiotherapie; lung cancer; oligo-métastases; oligometastases; stéréotaxie extracrânienne